CDC-held Tecovirimat EA-IND Protocol

Expanded Access IND Protocol “Use of Tecovirimat (TPOXX®) for Treatment of Human Non-Variola Orthopoxvirus Infections in Adults and Children” and CDC IRB approval letters for the protocol. Refer to the Tecovirimat (TPOXX) IND website for complete information.

Obtain informed consent prior to tecovirimat initiation.

Current EA-IND Protocol [494 KB, 28 pages] (version 6.4 updated June 5, 2024)

Protocol Amendment [372 KB, 2 pages] (version 6.4 updated June 5, 2024)

Protocol Continuation [93 KB, 1 page] (June 20, 2024)